论文信息 - Oblimersen sodium (Bcl-2 antisense) plus rituximab in patients with recurrent B-cell non-Hodgkin's lymphoma: Preliminary phase II results - 字舞流文

Oblimersen sodium (Bcl-2 antisense) plus rituximab in patients with recurrent B-cell non-Hodgkin's lymphoma: Preliminary phase II results

P. Mclaughlin | L. Fayad | A. Goy | F. Hagemeister | B. Pro | S. Frankel | J. Zwiebel | A. Younes | M. Rodriguez | Matthew R. Smith